The global burden of urinary bladder cancer

Global Cancer Statistics, 2002

Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,710

TNM Classification of Malignant Tumours

Hermanek, P., & Sobin, L. H. (1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,077

Cancer Incidence in Five Continents

Doll, R., Muir, C. S., & Waterhouse, J. A. H. (1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,485

Cancer Incidence in Five Continents

(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936

TNM Classification of Malignant Tumours

(2003) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471463752 · Cited by 3,968

Cancer incidence, mortality and prevalence worldwide

Ferlay, J. (2004) · Medical Entomology and Zoology · Cited by 3,796

The global health burden of infection‐associated cancers in the year 2002

Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932

Global Burden of Disease and Risk Factors

López, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T. T., & Murray, C. J. L. (2006) · World Bank, Washington, DC eBooks · doi:10.1596/978-0-8213-6262-4 · Cited by 2,714

Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) Program

Hayat, M. J., Howlader, N., Reichman, M. E., & Edwards, B. K. (2007) · The Oncologist · doi:10.1634/theoncologist.12-1-20 · Cited by 1,097

EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary

Sant, M., Aareleid, T., Berrino, F., Lasota, M. B., Carli, P., Faivre, J., Grosclaude, P., Hédelin, G., Matsuda, T., Møller, H., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg754 · Cited by 1,010

Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer

Lin, Y.-L., Wang, Y., Ma, J., & Li, W. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/preaccept-1759254111327153 · Cited by 32

Trends in cancer mortality rates among migrants in Australia: 1981–2007

Anikeeva, O., Bi, P., Hiller, J. E., Ryan, P., Roder, D. M., & Han, G. (2011) · Cancer Epidemiology · doi:10.1016/j.canep.2011.10.011 · Cited by 32

Chromosomal Instability, Aneuploidy and Routine High-Resolution DNA Content Analysis in Oral Cancer Risk Evaluation

Giaretti, W., Pentenero, M., GANDOLFO, S., & Castagnola, P. (2012) · Future Oncology · doi:10.2217/fon.12.116 · Cited by 31

Current intravesical therapy for non-muscle invasive bladder cancer

van Lingen, A. V., & Witjes, J. A. (2013) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2013.824421 · Cited by 30

NBN Gene Polymorphisms and Cancer Susceptibility: A Systemic Review

Berardinelli, F., di Masi, A., & Antoccia, A. (2013) · Current Genomics · doi:10.2174/13892029113146660012 · Cited by 30

Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis

Hashmi, A. A., Hussain, Z. F., Irfan, M., Edhi, M. M., Kanwal, S., Faridi, N., & Khan, A. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3319-4 · Cited by 29

Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder carcinoma after renal transplantation for end-stage aristolochic acid nephropathy

Roumeguère, T., Broeders, N., Jayaswal, A., Rorive, S., Quackels, T., Pozdzik, A. A., Arlt, V. M., Schmeiser, H. H., & Nortier, J. (2014) · Transplant International · doi:10.1111/tri.12484 · Cited by 29

A review of the infection-associated cancers in North African countries

Hussein, W. M., Anwar, W. A., Attaleb, M., Mazini, L., Försti, A., Trimbitas, R.-D., & Khyatti, M. (2016) · Infectious Agents and Cancer · doi:10.1186/s13027-016-0083-8 · Cited by 29

Molecular Markers in Sex Differences in Cancer

Shin, J. Y., Jung, H. J., & Moon, A. (2019) · Toxicological Research · doi:10.5487/tr.2019.35.4.331 · Cited by 28

Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer

Lin, Y.-L., Gui, S.-L., & Ma, J. (2015) · Oncology Letters · doi:10.3892/ol.2015.3337 · Cited by 28

Investigational cell cycle inhibitors in clinical trials for bladder cancer

Yun, S. J., Moon, S., & Kim, W. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.751097 · Cited by 27

Protosappanin B promotes apoptosis and causes G1 cell cycle arrest in human bladder cancer cells

Yang, X., Zhao, L., Zhang, T., Xi, J., Liu, S., Ren, L., Zheng, Y., & Zhang, H. (2019) · Scientific Reports · doi:10.1038/s41598-018-37553-z · Cited by 31

Developing biomarkers for improved diagnosis and treatment outcome monitoring of bladder cancer

Lintula, S., & Hotakainen, K. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.489546 · Cited by 26

Update on Intravesical Agents for Non-Muscle-Invasive Bladder Cancer

Shariat, S. F., Chade, D. C., Karakiewicz, P. I., Scherr, D. S., & Dalbagni, G. M. (2010) · Immunotherapy · doi:10.2217/imt.10.1 · Cited by 27

MMP7 and MMP8 genetic polymorphisms in bladder cancer patients

Wieczorek, E., Reszka, E., Wąsowicz, W., Grzegorczyk, A., Konecki, T., Sosnowski, M., & Jabłonowski, Z. (2013) · Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication · doi:10.5173/ceju.2013.04.art3 · Cited by 26

Diagnostic performance of diffusion-weighted MR imaging at 3.0 T in predicting muscle invasion in urinary bladder cancer: utility of evaluating the morphology of the reactive tumor stalk

Razik, A., Das, C. J., Sharma, S., Seth, A., Srivastava, D. N., Mathur, S. R., Kumar, R., & Gupta, A. K. (2018) · Abdominal Radiology · doi:10.1007/s00261-018-1458-7 · Cited by 26

Matriptase-Induced Phosphorylation of MET is Significantly Associated with Poor Prognosis in Invasive Bladder Cancer; an Immunohistochemical Analysis

Yamasaki, K., Mukai, S., Nagai, T., Nakahara, K., Fujii, M., Terada, N., Ohno, A., Sato, Y. Z., Toda, Y., Kataoka, H., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123708 · Cited by 26

Fractionated intravesical radioimmunotherapy with213Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma

Fazel, J., Rötzer, S., Seidl, C., Feuerecker, B., Autenrieth, M. E., Weirich, G., Bruchertseifer, F., Morgenstern, A., & Senekowitsch–Schmidtke, R. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1071735 · Cited by 26

Intravesical therapy for urothelial carcinoma of the urinary bladder: a critical review

Chade, D. C., Shariat, S. F., & Dalbagni, G. M. (2009) · International braz j urol · doi:10.1590/s1677-55382009000600002 · Cited by 26

Reexamination of Total Fluid Intake and Bladder Cancer in the Health Professionals Follow-Up Study Cohort

Zhou, J., Smith, S., Giovannucci, E. L., & Michaud, D. S. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kwr359 · Cited by 25

Low expression of protocadherin7 (PCDH7) is a potential prognostic biomarker for primary non-muscle invasive bladder cancer

Lin, Y.-L., Wang, Y., Fu, X.-L., Li, W., Wang, Y., & Ma, J. (2016) · Oncotarget · doi:10.18632/oncotarget.8635 · Cited by 25

The association between meat and fish consumption and bladder cancer risk: a pooled analysis of 11 cohort studies

Dianatinasab, M., Wesselius, A., de Loeij, T., Salehi‐Abargouei, A., Yu, E. Y.-W., Fararouei, M., Brinkman, M. T., van den Brandt, P. A., White, E., Weiderpass, E., et al. (2021) · European Journal of Epidemiology · doi:10.1007/s10654-021-00762-4 · Cited by 25

Expression of cell cycle–related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder☆

Youssef, R. F., Shariat, S. F., Kapur, P., Kabbani, W., Ghoneim, T. P., King, E., Cockburn, A., Mosbah, A., Abol‐Enein, H., & Ghoneim, M. A. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.07.012 · Cited by 24

Incidence and clinical characteristics of lower urinary tract symptoms as a presenting symptom for patients with newly diagnosed bladder cancer

Dobbs, R. W., Hugar, L. A., Revenig, L. M., Al-Qassab, U. A., Petros, J. A., Ritenour, C. W. M., Issa, M. M., & Canter, D. J. (2014) · International braz j urol · doi:10.1590/s1677-5538.ibju.2014.02.09 · Cited by 23

Synthesis and Functions of Well-defined Polymer-drug Conjugates as Efficient Nanocarriers for Intravesical Chemotherapy of Bladder Cancera

Yu, Q., Zhang, J., Zhang, G., & Gan, Z. (2014) · Macromolecular Bioscience · doi:10.1002/mabi.201400416 · Cited by 23

Identification of New Hub Genes Associated with Bladder Carcinoma via Bioinformatics Analysis

Jia, Z., Ai, X., Sun, F., Zang, T., Guan, Y., & Gao, F. (2015) · Tumori Journal · doi:10.5301/tj.5000196 · Cited by 23

The Role of Fascin in Migration and Invasion of Urothelial Carcinoma of the Bladder

Bi, J., Zhu, Y., Chen, X., Yu, M., Zhang, Y., Li, B.-X., Sun, J., Shen, H.-L., & Kong, C. (2013) · Urologia Internationalis · doi:10.1159/000346559 · Cited by 23

Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Using EORTC Risk Tables

Altieri, V. M., Castellucci, R., Palumbo, P., Verratti, V., Sut, M., Olivieri, R., Manco, R., Ricciardulli, S., Nicolai, M., Criniti, P., et al. (2012) · Urologia Internationalis · doi:10.1159/000336516 · Cited by 23

The N-butyl-N-4-hydroxybutyl Nitrosamine Mouse Urinary Bladder Cancer Model

Oliveira, P. A., Nóbrega, C., da Costa, R. M. G., & Arantes‐Rodrigues, R. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7234-0_13 · Cited by 23

Nur77 Inhibits Androgen-Induced Bladder Cancer Growth

Wu, J., Liu, J., Jia, R.-P., & Song, H. (2013) · Cancer Investigation · doi:10.3109/07357907.2013.853077 · Cited by 22

A plausible anti-apoptotic role of up-regulated OCT4B1 in bladder tumors.

Asadzadeh, J., Asadi, M. H., Shakhssalim, N., Rafiee, M., Kalhor, H. R., Tavallaei, M., & Mowla, S. J. (2012) · Urology journal./Urology jornal. · Cited by 22

Inhibiting Invasion into Human Bladder Carcinoma 5637 Cells with Diallyl Trisulfide by Inhibiting Matrix Metalloproteinase Activities and Tightening Tight Junctions

Shin, D. M., Cha, H., Kim, G., Kim, W., & Choi, Y. H. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141019911 · Cited by 21

Sex difference in presentation and outcomes of bladder cancer

Wolff, I., Brookman-May, S. D., & May, M. (2015) · Current Opinion in Urology · doi:10.1097/mou.0000000000000198 · Cited by 21

The impact of gender on oncologic outcomes of bladder cancer

Mun, D., Kimura, S., Shariat, S. F., & Abufaraj, M. M. (2019) · Current Opinion in Urology · doi:10.1097/mou.0000000000000606 · Cited by 21

Over-expression of HER-2 is associated with the stage in carcinomas of the urinary bladder

Gehani, K. E., Al-Kikhia, L., Emaetig, F. M., Syrjänen, K. J., Al-Fituri, O., & Elzagheid, A. I. (2012) · Libyan Journal of Medicine · doi:10.3402/ljm.v7i0.14694 · Cited by 21

Tissue and serum proteomic profiling for diagnostic and prognostic bladder cancer biomarkers

Schwamborn, K., Gaisa, N. T., & Henkel, C. (2010) · Expert Review of Proteomics · doi:10.1586/epr.10.82 · Cited by 20

Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence: A mini‐review

Wieczorek, E., Wąsowicz, W., Gromadzińska, J., & Reszka, E. (2014) · International Journal of Urology · doi:10.1111/iju.12431 · Cited by 20

LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk

for the Spanish Bladder Cancer/EPICURO Study investigators, Tajuddin, S. M., Amaral, A. F. S., Fernández, A. F., Chanock, S. J., Silverman, D. T., Tardón, A., Carrato, A., García‐Closas, M., Jackson, B. P., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.67 · Cited by 20

Germline mutations in DNA repair genes are associated with bladder cancer risk and unfavourable prognosis

Na, R., Wu, Y., Jiang, G., Yu, H., Lin, X., Wang, M., Conran, C., Fantus, R. J., Zhang, N., Liu, S., et al. (2018) · British Journal of Urology · doi:10.1111/bju.14370 · Cited by 20

Investigation of poorer bladder cancer survival in women in NSW , A ustralia: a data linkage study

Tracey, E. A., Watt, H., Currow, D. C., Young, J. M., & Armstrong, B. K. (2013) · British Journal of Urology · doi:10.1111/bju.12496 · Cited by 20

Bladder Cancer Stage Development, 2004-2014 in Europe Compared With the United States: Analysis of European Population-based Cancer Registries, the United States SEER Database, and a Large Tertiary Institutional Cohort

Schulz, G. B., Grimm, T., Büchner, A., Jokisch, F., Kretschmer, A., Stief, C. G., Knüchel, R., Kraywinkel, K., & Karl, A. (2019) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2019.10.008 · Cited by 20

Impact of hospital volume on local recurrence and distant metastasis in bladder cancer patients treated with radical cystectomy in Sweden

Sabir, E. F., Holmäng, S., Liedberg, F., Ljungberg, B., Malmström, P., Månsson, W., Wijkström, H., & Jahnson, S. (2013) · Scandinavian Journal of Urology · doi:10.3109/21681805.2013.787118 · Cited by 19

Cause–effect? Understanding the risk factors associated with bladder cancer

Bachir, B. G., & Kassouf, W. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.12.140 · Cited by 19

Cortex Moutan Induces Bladder Cancer Cell Death via Apoptosis and Retards Tumor Growth in Mouse Bladders

Lin, M., Lee, Y., Chiang, S., Li, Y., Chen, Y.-S., Hsu, C., & Liu, Y. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/207279 · Cited by 19

Curcumin-induced heme oxygenase-1 expression plays a negative role for its anti-cancer effect in bladder cancers

Wu, S., Lee, Y., Huang, C.-C., Li, Y.-Z., Chang, Y.-S., Yang, C.-Y., Wu, J., & Liu, Y. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.06.045 · Cited by 19

Gemcitabine for unresectable, locally advanced or metastatic bladder cancer

Shelley, M. D., Cleves, A., Wilt, T. J., & Mason, M. D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008976.pub2 · Cited by 19

The Use of Polymer Chitosan in Intravesical Treatment of Urinary Bladder Cancer and Infections

Erman, A., & Veranič, P. (2018) · Polymers · doi:10.3390/polym10030265 · Cited by 19

Expression of RFC/SLC19A1 is Associated with Tumor Type in Bladder Cancer Patients

Abdel‐Haleem, A. M., El-Zeiry, M. I., Mahran, L., Abou‐Aisha, K., Rady, M., Rohde, J., Mostageer, M., & Spahn-Langguth, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021820 · Cited by 18

A comprehensive evaluation of bladder cancer epidemiology and outcomes in Australia

Cheluvappa, R., Smith, D. P., Cerimagic, S., & Patel, M. I. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0643-z · Cited by 18

Correlation of mitotic indices, AgNor count, Ki-67 and Bcl-2 with grade and stage in papillary urothelial bladder cancer.

Goyal, S., Singh, U., Sharma, S., & Kaur, N. (2014) · Urology journal./Urology jornal. · Cited by 18

High Expression of Derlin-1 Is Associated with the Malignancy of Bladder Cancer in a Chinese Han Population

Wu, Z., Wang, C., Zhang, Z., Liu, W., Xu, H., Wang, H., Wang, Y., Zhang, W., & Wang, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168351 · Cited by 18

Helminth parasite proteomics: from experimental models to human infections

Mutapi, F. (2012) · Parasitology · doi:10.1017/s0031182011002423 · Cited by 18

Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis

Jin, N. Y., Jin, X., Xin-quan, G., Na, W., Zhang, M., & ZHAO, R. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3739 · Cited by 16

Progress in the Study of Chemical Structure and Pharmacological Effects of Total Paeony Glycosides Isolated from Radix Paeoniae Rubra

Sun, Y., Liu, T., & Zhao, X. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46090601 · Cited by 15

Screening of characteristic biomolecules related to bladder cancer based on construction of ceRNA regulation network

Sun, Y., Zhu, D., Xing, H., Hou, Y., & Liu, Y. (2020) · World Journal of Urology · doi:10.1007/s00345-020-03086-2 · Cited by 15

Effect of mitomycin C on concentrations of vascular endothelial growth factor and its receptors in bladder cancer cells and in bladders of rats intravesically instilled with mitomycin C

Verma, A., DeGrado, J., Hittelman, A. B., Wheeler, M. A., Kaimakliotis, H. Z., & Weiss, R. M. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2010.09543.x · Cited by 15

Detection of smoothelin expression in the urinary bladder is strongly dependent on pretreatment conditions: a critical analysis with possible consequences for cancer staging

Lindh, C., Nilsson, R., Lindström, M.-L., Lundin, L., & Elmberger, G. (2011) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-011-1076-z · Cited by 15

Promoter methylation of H-cadherin is a potential biomarker in patients with bladder transitional cell carcinoma

Lin, Y.-L., Liu, X., Li, W., Sun, G., & Zhang, C. (2011) · International Urology and Nephrology · doi:10.1007/s11255-011-9961-6 · Cited by 15

Aristolochic Acid and Immunotherapy for Urothelial Carcinoma: Directions for unmet Needs

Yang, H., Yang, C., Wu, C., Wang, L.-J., & Lu, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133162 · Cited by 15

Cyclooxygenase-2 Expression in Urinary Bladder Transitional Cell Carcinoma and its Association with Clinicopathological Characteristics

Tabriz, H. M., Olfati, G., Ahmadi, S. A., & Yusefnia, S. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.8.4539 · Cited by 14

Efficacy and Safety of Stroke Volume Variation-Guided Fluid Therapy for Reducing Blood Loss and Transfusion Requirements During Radical Cystectomy

Kong, Y., Kim, J. Y., Yu, J., Lim, J., Hwang, J., & Kim, Y. (2016) · Medicine · doi:10.1097/md.0000000000003685 · Cited by 14

The Correlation Between Bladder Cancer and Obesity, Overweight, Physical Inactivity, and Tobacco Use: An Ecological Study in Asian Countries

Rezaei, F., Tabatabaee, H., Rahmanian, V., Mirahmadizadeh, A., & Hassanipour, S. (2019) · Annals of Global Health · doi:10.5334/aogh.2545 · Cited by 13

Vinflunine in the treatment of advanced bladder cancer

Mamtani, R., & Vaughn, D. J. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.196 · Cited by 14

Snail is an independent prognostic indicator for predicting recurrence and progression in non-muscle-invasive bladder cancer

Gou, Y., Ding, W., Ke Cheng, X. U., Wang, H., Chen, Z., Tan, J., Xia, G., & Ding, Q. (2014) · International Urology and Nephrology · doi:10.1007/s11255-014-0874-z · Cited by 13

Bladder Cancer is Associated with Low Plasma 25-hydroxyvitamin D Concentrations in Tunisian Population

Fradj, M. K. B., Gargouri, M. M., Hammami, B., Rhouma, S. B., Kallel, A., Jemaa, R., Feki, M., Nouira, Y., & Kaabachi, N. (2016) · Nutrition and Cancer · doi:10.1080/01635581.2016.1134598 · Cited by 13

The epidemiological status of urogenital schistosomiasis among reproductive aged individuals in the Tiko Health Area- a semi-urban setting in the Mount Cameroon area

Ndassi, V. D., Anchang-Kimbi, J. K., Sumbele, I. U. N., Ngufor, L., Kouémou, N. E., & Kimbi, H. K. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008978 · Cited by 13

Significant Implications of APOA1 Gene Sequence Variations and Its Protein Expression in Bladder Cancer

Magray, J. A., Pandith, A. A., Qasim, I., Khateeb, M., Hamid, A., Koul, A. M., Shah, Z. A., Baba, S. M., Mansoor, S., Charifi, W., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9080938 · Cited by 12

Laparoscopic radical cystectomy

Fergany, A. F. (2012) · Arab Journal of Urology · doi:10.1016/j.aju.2012.01.003 · Cited by 12

Sodium valproate, a histone deacetylase inhibitor, with praziquantel ameliorates Schistosoma mansoni -induced liver fibrosis in mice

Elsakkar, M. G., Eissa, M. M., Hewedy, W. A., Nassra, R. A., & Elatrebi, S. F. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.08.010 · Cited by 12

Chronic Infections of the Urinary Tract and Bladder Cancer Risk: a Systematic Review

Anderson-Otunu, O., & Akhtar, S. (2016) · PubMed · doi:10.14456/apjcp.2016.173 · Cited by 12

High-grade urothelial bladder cancer in children: A case report and critical analysis of the literature

Král, M., Michálek, J., Škarda, J., Tichý, T., Šmakal, O., Kodet, R., & Študent, V. (2016) · Biomedical Papers · doi:10.5507/bp.2016.045 · Cited by 11

Risk factor assessment in high-risk, bacillus Calmette–Guérin-treated, non-muscle-invasive bladder cancer

Holz, S., Albisinni, S., Gilsoul, J., Pirson, M. A., Duthie, V., Quackels, T., Bossche, M. V., & Roumeguère, T. (2017) · Research and Reports in Urology · doi:10.2147/rru.s143865 · Cited by 11

trans -10, cis -12 Conjugated Linoleic Acid Inhibits Insulin-Like Growth Factor-I Receptor Signaling in TSU-Pr1 Human Bladder Cancer Cells

Jung, J. I., Cho, H., Kim, J., Kwon, D. Y., & Park, J. H. Y. (2010) · Journal of Medicinal Food · doi:10.1089/jmf.2009.1201 · Cited by 11

Role of fibroblast growth factor in squamous cell carcinoma of the bladder: Prognostic biomarker and potential therapeutic target

Youssef, R. F., Kapur, P., Mosbah, A., Abol‐Enein, H., Ghoneim, M. A., & Lotan, Y. (2014) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2014.09.020 · Cited by 11

Reducing understaging of bladder cancer with the aid of photodynamic cystoscopy

Sfetsas, K., & Mitropoulos, D. N. (2016) · Journal of the Egyptian National Cancer Institute · doi:10.1016/j.jnci.2016.03.002 · Cited by 11

Survival of patients with transitional cell carcinoma of the urinary bladder in indonesia: a single institution review.

Supit, W., Mochtar, C. A., Sugiono, M., & Umbas, H. R. (2011) · PubMed · Cited by 11

A multifactor dimensionality reduction-logistic regression model of gene polymorphisms and an environmental interaction analysis in cancer research.

Wu, Y., Zhang, L., Liu, L., Zhang, Y., Zhao, Z., Liu, X., & Yi, D. (2011) · PubMed · Cited by 11

Burden and Pattern of Cancer in the Sudan, 2000-2006

Mohammed, M. (2014) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2014/6863 · Cited by 11

Soft Extrudable Dendritic Particles with Nanostructured Tendrils for Local Adhesion and Drug Release to Bladder Cancers

Lee, J. G., Petraccione, J., Trese, K. A., Hughes, A. C., Ausec, T. R., Salzmann‐Sullivan, M., Su, L., Kim, M. T., Roh, S., Goodwin, A. P., et al. (2025) · Advanced Materials · doi:10.1002/adma.202505231 · Cited by 10

Functional RsaI/PstI Polymorphism in Cytochrome P450 2E1 Contributes to Bladder Cancer Susceptibility: Evidence from a Meta-analysis

Deng, X., Gao, Q. F., Zhang, B., Zhang, L., Zhang, W., Er, Z.-E. M., Xie, Y., Ma, Y., & Liu, Y. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.12.4977 · Cited by 10

Epidemiology of Bladder Cancer in the Arab World: 2019 Global Burden of Disease Data

Saidi, I. A., Mohamedabugroon, A., Sawalha, A., & Sultan, I. Y. (2022) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2022.23.9.2907 · Cited by 10

Significant Correlation between Chromosomal Aberration and Nuclear Morphology in Urothelial Carcinoma

Shuto, M., Seyama, A., Gotoh, Y., Kamada, K., Nakamura, M., Warigaya, K., Watanabe, H., Ueno, M., Shimizu, M., Fukuda, T., et al. (2012) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.11048 · Cited by 10

TP53 codon 72 Polymorphism and bladder cancer risk: a meta-analysis and emphasis on the role of tumor or smoking status

Zhang, L., Wang, Y., Qin, Z., Li, R., Cong, R., Ji, C., Meng, X., Wang, Y., Xia, J., & Song, N. (2018) · Journal of Cancer · doi:10.7150/jca.26264 · Cited by 10

GPR137 is a promising novel bio-marker for the prognosis of bladder cancer patients

Jian-lei, L., Zhong, F., Sun, B., & Wang, C. (2019) · Medicine · doi:10.1097/md.0000000000016576 · Cited by 10

Anti-Proliferative Effects of Lidocaine as an Autophagy Inducer in Bladder Cancer via Intravesical Instillation: In Vitro and Xenograft Mouse Model Experiments

Yoo, Y. C., Kim, N. Y., Shin, S., Yang, Y., Jun, J. H., Oh, J. E., & Kim, M. H. (2024) · Cancers · doi:10.3390/cancers16071267 · Cited by 9

Squamous Cell Bladder Cancer: A Rare Histological Variant with a Demand for Modern Cancer Therapeutics

Bell, S. D., Quinn, A. E., Bajo, A., Mayberry, T. G., Cowan, B. C., Marrah, A. J., Wakefield, M. R., & Fang, Y. (2025) · Cancers · doi:10.3390/cancers17020169 · Cited by 9

Bioinformatics analysis of the target gene of fibroblast growth factor receptor 3 in bladder cancer and associated molecular mechanisms

Ai, X., Jia, Z., Wang, J., Di, G.-P., Zhang, X., Sun, F., Zang, T., & Liao, X.-M. (2015) · Oncology Letters · doi:10.3892/ol.2015.3231 · Cited by 9

Prognostic Value of Cyclooxygenase-2 Expression in Squamous Cell Carcinoma of the Bladder

Youssef, R. F., Shariat, S. F., Kapur, P., Kabbani, W., Mosbah, A., Abol‐Enein, H., Ghoniem, M. A., & Lotan, Y. (2011) · The Journal of Urology · doi:10.1016/j.juro.2010.10.036 · Cited by 9

Incidence of Bladder Cancer in Sri Lanka: Analysis of the Cancer Registry Data and Review of the Incidence of Bladder Cancer in the South Asian Population

Ranasinghe, W. K. B., Silva, D. D., Silva, M. V. C. D., Ranasinghe, T., Lawrentschuk, N., Bolton, D. M., & Persad, R. A. (2012) · Korean journal of urology · doi:10.4111/kju.2012.53.5.304 · Cited by 9

Small-area spatio-temporal analyses of bladder and kidney cancer risk in Nova Scotia, Canada

Saint‐Jacques, N., Lee, J. S. W., Brown, P., Stafford, J. E., Parker, L., & Dummer, T. (2016) · BMC Public Health · doi:10.1186/s12889-016-2767-9 · Cited by 9

Folic Acid Modified Polymeric Micelles for Intravesical Instilled Chemotherapy

Zhou, D., Zhang, G., Yu, Q., & Gan, Z. (2017) · Chinese Journal of Polymer Science · doi:10.1007/s10118-018-2009-y · Cited by 9

Assessing treatment response after intravesical bacillus Calmette–Guerin induction cycle: are routine bladder biopsies necessary?

Calò, B., Sanguedolce, F., Falagario, U. G., Chirico, M., Fortunato, F., Carvalho‐Dias, E., Busetto, G. M., Bettocchi, C., Carrieri, G., & Cormio, L. (2021) · World Journal of Urology · doi:10.1007/s00345-021-03690-w · Cited by 9

Gemcitabine for unresectable, locally advanced or metastatic bladder cancer

Shelley, M. D., Cleves, A., Wilt, T. J., & Mason, M. D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008976 · Cited by 9

Intravesical gemcitabine for non-muscle invasive bladder cancer

Jones, G., Cleves, A., Wilt, T. J., MASON, M. D., Kynaston, H., & Shelley, M. D. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009294 · Cited by 9

The Importance of Reporting Clinical and Epidemiological Data in Urology: Local Experiences and Insights from the International Literature

Gajdács, M. (2020) · Medicina · doi:10.3390/medicina56110581 · Cited by 8

Investigation toward the economic feasibility of personalized medicine for healthcare service providers: the case of bladder cancer

Savchenko, E. V., & Bunimovich‐Mendrazitsky, S. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1388685 · Cited by 7

The Use of Regenerative Medicine in the Management of Invasive Bladder Cancer

Hyndman, M. E., Kaye, D. R., Field, N. C., Lawson, K. A., Smith, N. D., Steinberg, G. D., Schoenberg, M., & Bivalacqua, T. J. (2012) · Advances in Urology · doi:10.1155/2012/653652 · Cited by 8

Microbiological investigation of an antibacterial sandwich layer system

Zare, H. H., Sudhop, S., Schamberger, F., & Franz, G. (2014) · Biointerphases · doi:10.1116/1.4876736 · Cited by 8

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

Antoni, S., Ferlay, J., Soerjomataram, I., Znaor, A., Jemal, A., & Bray, F. (2017) · European Urology · doi:10.1016/j.eururo.2016.06.010 · Cited by 2,514

Urinary bladder cancer Trends Incidence Mortality

Saurabh Chavan, A., Freddie Bray, B., Lortet‐Tieulent, J., Michael Goodman, C., Ahmedin Jemal, A., & Haematobium, S. (2013)

Recent patterns of bladder cancer incidence and mortality: a global overview

Mohammadian, M., Safari, A., Bakeshei, K. A., Bakeshei, F. A., Asti, A. D., Mohammadian-Hafshejani, A., Salehiniya, H., Emamiyan, M., & Khakpour, H. (2020) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.32113/wcrj_20201_1464 · Cited by 18

International Variations in Bladder Cancer Incidence and Mortality

Chavan, S., Bray, F., Lortet‐Tieulent, J., Goodman, M. M., & Jemal, A. (2013) · European Urology · doi:10.1016/j.eururo.2013.10.001 · Cited by 349

The global burden of urinary bladder cancer: an update

Richters, A., Aben, K. K. H., & Kiemeney, L. A. L. M. (2019) · World Journal of Urology · doi:10.1007/s00345-019-02984-4 · Cited by 972